The Role of IN PACT

 

 

  • In-stent restenosis pathophysiology 
  • Limitations and barriers to successful ISR treatment 
  • IN.PACT Global Study 5-year results for the prespecified long lesion, CTOs, and ISR cohorts 
  • Long femoropopliteal lesion, CTO, and ISR case examples 
  • Discussion of treatment strategies and best practices when using IN.PACT Admiral in complex cases
     

 

MODERATORS

John Laird Circle  


 

John Laird, M.D.
Chief Medical Officer Medtronic
Peripheral Vascular Health



 

Osamu Iida, M.D.   Osamu Iida, M.D.
Kansai Rosai Hospitial
Itami, Japan

 
     

CHAIRS

Yoshimitsu Soga Circle  

Yoshimitsu Soga, M.D.
Kokura Memorial Hospital
Kitakyushu, Japan



 
Masahiko Fujihara   Masahiko Fujihara, M.D
Kishiwada Tokushukai Hospital
Osaka, Japan

 
     

PANELISTS

Peter Schneider  


 

Peter Schneider, M.D.
University of California
San Francisco
San Francisco, CA



 

Sahil A. Parikh  

Sahil Parikh​, M.D.
Columbia University
Irving Med Center
New York City, NY​

Ravish Sachar   Ravish Sachar​, M.D.
UNC-REX Healthcare
Raleigh, NC

 

 

DISCLAIMER

Content in this video is intended for healthcare professionals in countries with applicable health authority product registrations. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to use. If not approved, please exit this site.

 


This program is sponsored by:   Medtronic

 

2021-11-02T10:01:56Z